poisar

Stocks · News reference

This Plexus Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

BenzingaAvi Kapoor

Analysts upgraded MetLife, Brinker, Plexus, West Pharma and Omeros, raising ratings and price targets.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolJeremy Bowman

    Why Brinker International Stock Jumped Today

    Brinker International (Chili's parent company) stock rose 3.49% after Northcoast upgraded the stock from neutral to buy with a $275 price target, implying 37% upside. The upgrade was driven by strong growth at Chili's, menu improvements, better marketing, and management confidence in achieving in-store margins exceeding 20%. While hypergrowth may be slowing, the company targets 4%-6% annual revenue growth through fiscal 2029 with double-digit adjusted EPS growth.

  2. Zacks Investment ResearchNa

    Can MetLife's Group Benefits Segment Maintain Its Momentum?

    MetLife's Group Benefits segment reported 25% year-over-year earnings growth in Q2 2026, driven by volume growth and improved underwriting. Group Life's mortality ratio improved to 79%, below the 83%-88% target range. However, some mortality benefits may not persist as about 2 percentage points reflected prior-period development. Competitors The Hartford and Aflac showed mixed results, with Hartford's employee benefits expanding but facing higher disability loss ratios, while Aflac's earnings declined despite sales growth.